The Reply - 19/05/18
Doi : 10.1016/j.amjmed.2018.01.052
Le texte complet de cet article est disponible en PDF.
| Funding: None. |
|
| Conflicts of Interest: SP reports grants from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (HL138377, HL095799), grants from Patient Centered Outcomes Research Institute (IHS-1306-02505, EAIN #3394-UoA, and PPRND-1507-31666), grants from the Department of Defense (PT130770), grants from the NIH (National Cancer Institute; R21CA184920), grants from the Johrei Institute, grants from the American Sleep Medicine Foundation, personal fees from the American Academy of Sleep Medicine, personal fees from the American College of Chest Physicians, nonfinancial support from the National Center for Sleep Disorders Research of the NIH (NHLBI), personal fees from UpToDate Inc., Philips-Respironics, Inc., Bayer, Inc., and Vapotherm, Inc.; grants from Younes Sleep Technologies, Ltd., Niveus Medical Inc., and Philips-Respironics, Inc. outside the submitted work. In addition, SP has a patent: UA 14-018 U.S.S.N. 61/884,654; PTAS 502570970 (Home breathing device). We note that Philips-Respironics, Inc. manufactures positive airway pressure therapy devices. |
© 2018
Elsevier Inc. Tous droits réservés.
Vol 131 - N° 6
P. e271 - juin 2018 Retour au numéro
Article précédent
- Effect of Positive Airway Pressure on Hospitalization in Patients with Chronic Obstructive Pulmonary Disease
- Tomoyuki Kawada
- Aorta–Aorta Fistula: Another Uncommon Cause of Heart Failure
- Chieh-Jen Wu, Tung-Ho Wu, Hsing-Lin Lin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?